Amplify Weight Loss Drug & Treatment ETF (THNR) — ETF Analysis on Winston

Key Facts

• Issuer: Amplify
• Category: Equity
• Asset Class: Equity
• Price: $27.53
• Expense Ratio: 59.00%
• Assets Under Management: $6M
• Number of Holdings: 20
• Inception Date: 2024-05-21
• Currency: USD

Winston Score

Amplify Weight Loss Drug & Treatment ETF has a Winston Score of 39 out of 100.

Top Holdings

Eli Lilly & Co (N/A%), Novo Nordisk A/S (N/A%), Regeneron Pharmaceuticals Inc (N/A%), Innovent Biologics Inc (N/A%), Amgen Inc (N/A%)

Sector Breakdown

Cash & Others (N/A%), Financial Services (N/A%), Healthcare (N/A%)